000			02081 a2200565 4500
005			20250515062035.0
264		0	_c20070807
008			200708s 0 0 eng d
022			_a0007-1188
024	7		_a10.1038/sj.bjp.0707160 _2doi
040			_aNLM _beng _cNLM
100	1		_aDepoortère, R
245	0	0	_aF15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms. _h[electronic resource]
260			_bBritish journal of pharmacology _cMay 2007
300			_a266-77 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmnesia _xphysiopathology
650	0	4	_aAnimals
650	0	4	_aAntipsychotic Agents _xpharmacology
650	0	4	_aBehavior, Animal _xdrug effects
650	0	4	_aBenzofurans _xpharmacology
650	0	4	_aBenzylamines _xpharmacology
650	0	4	_aCognition Disorders _xchemically induced
650	0	4	_aCyclopentanes _xpharmacology
650	0	4	_aDopamine Agonists _xpharmacology
650	0	4	_aDopamine Antagonists _xpharmacology
650	0	4	_aDopamine D2 Receptor Antagonists
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aMale
650	0	4	_aModels, Animal
650	0	4	_aPhencyclidine
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Dopamine D3 _xantagonists & inhibitors
650	0	4	_aReceptors, Dopamine D4 _xagonists
650	0	4	_aReflex _xdrug effects
650	0	4	_aReflex, Startle _xdrug effects
650	0	4	_aSerotonin 5-HT1 Receptor Agonists
650	0	4	_aSerotonin 5-HT1 Receptor Antagonists
650	0	4	_aSerotonin Receptor Agonists _xpharmacology
700	1		_aAuclair, A L
700	1		_aBardin, L
700	1		_aBruins Slot, L
700	1		_aKleven, M S
700	1		_aColpaert, F
700	1		_aVacher, B
700	1		_aNewman-Tancredi, A
773	0		_tBritish journal of pharmacology _gvol. 151 _gno. 2 _gp. 266-77
856	4	0	_uhttps://doi.org/10.1038/sj.bjp.0707160 _zAvailable from publisher's website
999			_c16929929 _d16929929